MEGIN Spotlights

In this Spotlight, we welcome Srikantan Nagarajan, PhD, a Professor in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco. Professor Nagarajan explains how MEG technology is utilized in the brain tumor and epilepsy treatment programs at UCSF. He also offers insights on how UCSF runs a successful MEG program and achieves an ROI on this modality.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

We were delighted to welcome Caregiver Melinda Blalock to our Spotlight series. Melinda was kind enough to share her son's epilepsy journey through 4 different pediatric hospitals, and his eventual MEG scan at Le Bonheur Children's Hospital. We hear how the inclusion of MEG during her son's epilepsy evaluation at Le Bonheur enabled new clinical decision making – which ultimately led to positive changes to his epilepsy, allowing for a more free and independent life with the amazing support of his family.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

We were delighted to welcome Simon Vogrin and Professor Chris Plummer to our Spotlight today. Together, they are the Managing Directors and co founders of EMSL, a privately run center in Melbourne which uses MEG technology in collaboration with Swinburne University of Technology.

Listen to our guests discuss the role of the EMSL center and MEG, with Professor Plummer being one of the only neurologists in Australia to incorporate MEG in patient work ups. They share specific clinical and research cases and discuss why they choose to use MEG as a part of a multi modal neuroimaging treatment plan.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

In this Spotlight we welcome Professor Hanna Renvall, head of the MEG Lab at BioMag Laboratory at Helsinki University Hospital, to discuss how MEG is incorporated at the institution. Professor Renvall shares preliminary insights into the AI Mind research project, which incorporates MEG technology to assess the risk of developing clinical dementia in the near future. Professor Renvall also discusses her findings on a research study where MEG was combined with machine learning to classify mild traumatic brain injuries, and how she sees MEG being used in the future.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

In this Spotlight, we welcome Professor Krish Singh, Head of Human Electrophysiology at Cardiff University Brain Research Imaging Centre. Professor Singh's group uses MRI, EEG, and MEG. The group has collaborated on research such as epilepsy, schizophrenia, and Alzheimer's disease. In this Spotlight, Professor Singh discusses two major multi-modal research projects running with MEG and explains how Cardiff are exploring using MEG technology as an exciting new tool for pharma to help accelerate and improve drug development pipelines.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

We are pleased to release a new MEGIN Spotlight with Dr. Jeffrey Tenney, Clinical Director of MEG at Cincinnati Children's Hospital Medical Center.

In this Spotlight, Dr Tenney shares a case study illustrating how MEG technology was vital in the diagnostic process of a patient and changed the surgical outcome. Dr Tenney also discusses his work as President of ACMEGs and gives insight into research projects at Cincinnati Children's Hospital.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

We were delighted to welcome to the Spotlight Dr. Olga Taraschenko, Dr. Valentina Gumenyuk and Dr. Matthew Rizzo from the University of Nebraska Medical Center (UNMC). UNMC has a long history as a MEG site in the United States, and recently upgraded to MEGIN's TRIUX™ neo. In this Spotlight, our guests describe how UNMC utilizes MEG technology for both clinical services and research initiatives, including epilepsy, memory and sleep disorders.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

It was a pleasure welcoming our guest Dr. Sarah Weatherspoon to the Spotlight. Dr. Weatherspoon is a Pediatric Neurologist at Le Bonheur Children's Hospital. In this interview, Dr. Weatherspoon discusses how she discovered MEG technology, the importance of finding a MEG center for her first attending position, and how the technology is incorporated into the workflow at the EMU today. Dr. Weatherspoon explains why using MEG is always high on her priority list, and shares one patient's incredible epilepsy journey where MEG was instrumental in guiding the hospital team. This patient was previously not considered a surgical candidate but with the data from a MEG scan and the following surgery, the patient has gone from hundreds of seizures a day to two and a half months seizure free.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

MEGIN was pleased to welcome caregiver Amy Godknecht to share her daughter Autumn's epilepsy journey through multiple medications and surgeries. She provides information about when the family was first introduced to MEG technology and the reassurance it provided in the family's decision-making. As Amy explains, the family decided to pursue surgery for a second time because they could gather more data with MEG technology. Amy gives insight into the excellent care that Autumn received at Cook Children's Hospital and the current process of transitioning from a pediatric to an adult epilepsy care team. She highlights the importance of access to testing and expertise as Autumn moves into this next stage of her epilepsy journey as an adult.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

In this Spotlight, Professor Beniczky explains the evolution of MEG's utilization in his clinical and research career. He discusses how MEG is incorporated into the operational flow at the Danish Epilepsy Center and explains the importance of MEG in pre-surgical epilepsy evaluations and assessing patients' viability for epilepsy surgery. Professor Beniczky also offers insights into how MEG has helped to facilitate epilepsy research conducted by his department and gives insights into the clinical added value in pre-surgical evaluation.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.